Difficult-to-interpret dopamine transporter SPECT with [123I]ioflupane in the diagnosis of parkinsonism
Nuklearmedizin - NuclearMedicine · 01.04.2026 · 65 (02) · 83-92
DOI: 10.1055/a-2784-7591 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nuklearmedizin - NuclearMedicine, erschienen am 01.04.2026. Verfasst von Ivayla Ilieva Apostolova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Tomography, Emission-Computed, Single-Photon, Dopamine Plasma Membrane Transport Proteins, Nortropanes, Parkinsonian Disorders.
Abstract (Originalsprache)
Aim
To estimate (i) the rate of difficult-to-interpret cases in dopamine transporter (DAT)-SPECT with [123I]ioflupane and (ii) the diagnostic accuracy of binary visual categorization in difficult-to-interpret DAT-SPECT.
Methods
The study included 178 control subjects (49% females, 63.7±11.7y) and 178 sex- and age-matched patients with pre-screening clinical diagnosis of Parkinson’s disease (PD) from the Parkinson’s Progression Markers Initiative (PPMI). SPECT images reconstructed by the PPMI and a local method were visually interpreted twice by 2 independent readers with respect to Parkinson-like reduction of the striatal signal using the following 6-score: –3 = clearly reduced, –2 = probably reduced, –1 = more likely reduced than normal, 1 = more likely normal than reduced, 2 = probably normal, 3 = clearly normal. Cases with 6-score of –1 or 1 were considered “difficult-to-interpret”, all other cases were considered “conclusive”. To assess diagnostic accuracy relative to the clinical group label (control, PD), the 6-score was binarized using 0 as cutoff.
Results
The proportion of difficult-to-interpret cases ranged between 3.4% (95%-CI 1.5–5.2%) and 7.6% (4.8–10.3%) across readers and reconstruction methods. The proportion of cases misclassified by the binarized score ranged between 17.4% (1.9–32.9%) and 50.0% (25.5–74.5%) among the difficult-to-interpret cases, and between 5.1% (2.7–7.4%) and 6.4% (3.8–9.0%) among the conclusive cases.
Conclusions
(i) the proportion of difficult-to-interpret cases in DAT-SPECT for the diagnosis of parkinsonism is not larger than 10%, (ii) the diagnostic accuracy of binary decisions is severely reduced in these cases. We therefore recommend reporting difficult-to-interpret cases as “inconclusive”, unless in special situations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- jung diagnostics GmbH, Hamburg, Germany.
- Department of Nuclear Medicine, University Hospital Freiburg, Freiburg, Germany.
Zitieren
APA
Apostolova, I. I., Buddenkotte, T., Jedid, L., Klutmann, S., Braren, R., Meyer, P. T., & Buchert, R. (2026). Difficult-to-interpret dopamine transporter SPECT with [123I]ioflupane in the diagnosis of parkinsonism. Nuklearmedizin - NuclearMedicine, 65(02), 83-92. https://doi.org/10.1055/a-2784-7591
Vancouver
Apostolova II, Buddenkotte T, Jedid L, Klutmann S, Braren R, Meyer PT, et al. Difficult-to-interpret dopamine transporter SPECT with [123I]ioflupane in the diagnosis of parkinsonism. Nuklearmedizin - NuclearMedicine. 2026;65(02):83-92. doi:10.1055/a-2784-7591
BibTeX
@article{Apostolova2026,
author = {Apostolova, Ivayla Ilieva and Buddenkotte, Thomas and Jedid, Loren and Klutmann, Susanne and Braren, Rickmer and Meyer, Philipp T and Buchert, Ralph},
title = {Difficult-to-interpret dopamine transporter SPECT with [123I]ioflupane in the diagnosis of parkinsonism},
journal = {Nuklearmedizin - NuclearMedicine},
year = {2026},
volume = {65},
number = {02},
pages = {83--92},
doi = {10.1055/a-2784-7591}
}
EUVIMED